Dastur J K, Forshaw M J, Modarai B, Solkar M M, Raymond T, Parker M C
Department of General Surgery, Darent Valley Hospital, Dartford, Kent, UK.
Tech Coloproctol. 2008 Mar;12(1):51-5. doi: 10.1007/s10151-008-0399-5. Epub 2008 May 30.
Self-expanding metallic stents (SEMS) are now regarded as a safe and effective treatment for an acute obstructing colorectal cancer. SEMS insertion is an invasive procedure that could potentially worsen prognosis. This study assessed the short-and long-term outcomes in patients stented for acute large bowel obstruction and in patients who underwent primary emergency surgery.
We retrospectively identified 19 patients who underwent SEMS insertion and 23 patients who had primary emergency surgery for left-sided large bowel obstruction as the first presentation of colorectal cancer.
There were no significant differences between the 19 patients in the SEMS group and the 23 patients in the primary emergency surgery group in terms of demographics and tumour location and stage. Stent insertion was successful in 16 patients (84%). One patient died from a stent-related perforation and another had a stoma fashioned for stent migration. Stents were a definitive procedure in 2 patients with advanced disease and acted as a "bridge to surgery" in the remaining 12 patients. Compared to the primary surgery group, there was a trend towards a higher primary anastomosis rate in the SEMS group (p=0.08); there were no significant differences in length of hospital stay, 30-day mortality or complication rates between the groups. Long-term prognosis (estimated 3-year survival) did not differ significantly between the groups (p=0.54); this persisted when only curative resections were considered (p=0.80).
Preoperative stent insertion is a safe and effective treatment for large bowel obstruction, and may result in a higher primary anastomosis rate. Stent insertion does not seem to have a deleterious effect on prognosis.
自膨式金属支架(SEMS)目前被视为治疗急性梗阻性结直肠癌的一种安全有效的方法。SEMS置入是一种侵入性操作,可能会使预后恶化。本研究评估了因急性大肠梗阻置入支架的患者和接受一期急诊手术的患者的短期和长期结局。
我们回顾性确定了19例行SEMS置入的患者和23例因左侧大肠梗阻作为结直肠癌的首次表现而接受一期急诊手术的患者。
SEMS组的19例患者和一期急诊手术组的23例患者在人口统计学、肿瘤位置和分期方面无显著差异。16例患者(84%)支架置入成功。1例患者死于与支架相关的穿孔,另1例因支架移位而行造口术。支架对2例晚期疾病患者是一种确定性治疗方法,对其余12例患者则起到“手术桥梁”的作用。与一期手术组相比,SEMS组的一期吻合率有升高趋势(p=0.08);两组之间在住院时间、30天死亡率或并发症发生率方面无显著差异。两组之间的长期预后(估计3年生存率)无显著差异(p=0.54);仅考虑根治性切除时也是如此(p=0.80)。
术前置入支架是治疗大肠梗阻的一种安全有效的方法,可能会使一期吻合率更高。支架置入似乎对预后没有有害影响。